Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia, Myeloid, Acute 155Leukemia 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 86Leukemia, Myelomonocytic, Acute 31Leukemia, Monocytic, Acute 31Leukemia, Erythroblastic, Acute 27Leukemia, Megakaryoblastic, Acute 25Congenital Abnormalities 23Burkitt Lymphoma 19Myelodysplastic Syndromes 17Lymphoma 17Leukemia, Biphenotypic, Acute 14Anemia, Refractory, with Excess of Blasts 11Myeloproliferative Disorders 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, Eosinophilic, Acute 8Leukemia, Basophilic, Acute 8Neoplasm, Residual 7Leukemia, Promyelocytic, Acute 7Leukemia, Myelomonocytic, Chronic 7Recurrence 6Dendritic Cell Sarcoma, Interdigitating 5Hematologic Neoplasms 4Thrombocytopenia 3Neutropenia 3Neoplasms 3Myelodysplastic-Myeloproliferative Diseases 3Lymphoma, Non-Hodgkin 3Down Syndrome 3Thrombocythemia, Essential 2

Interventions

Cytarabine 14fludarabine 13venetoclax 11Imatinib Mesylate 9Cyclophosphamide 8Azacitidine 8fludarabine phosphate 7Busulfan 7Whole-Body Irradiation 6Tacrolimus 6Mycophenolic Acid 6thymoglobulin 4ponatinib 4nilotinib 4Sirolimus 4Peripheral Blood Stem Cell Transplantation 4Methotrexate 4asciminib 3aldesleukin 3Melphalan 3Interleukin-2 3Idarubicin 3Granulocyte Colony-Stimulating Factor 3Filgrastim 3Decitabine 3Bone Marrow Transplantation 3Antilymphocyte Serum 3zosuquidar trihydrochloride 2gilteritinib 2enasidenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Myeloid × Daunorubicin × Clear all
NCT00111345 2012-05-23

Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents

University Hospital Muenster

Phase 2/3 Unknown
550 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT00129168 2008-04-01

Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML)

Kanisa Pharmaceuticals

Phase 1/2 Completed
100 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Recurrence, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡